Rare diseases
Investigational molecules
Locations
Back to Bulgaria442 clinical trials in Plovdiv, Bulgaria across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
A Phase III Study of Lenbelintide in Adults with Obesity or Overweight and Weight‑Related Comorbidity Without Type 2 Diabetes
BulgariaPhase 3 Randomized, Double‑Blind Study of Telitacicept versus Placebo for Efficacy and Safety in Adults with Active Primary Sjögren’s Disease
BulgariaEffect of laroprovstat/rosuvastatin combination versus laroprovstat, rosuvastatin, and placebo on LDL‑C in hypercholesterolemia patients not previously treated with lipid‑lowering therapy
BulgariaEfficacy and Safety of REGN7508, REGN9933, and Rivaroxaban in Adults with Peripheral Artery Disease after Recent Lower‑Extremity Revascularization
BulgariaPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
BulgariaRandomized Placebo‑Controlled Trial of Cenerimod for Efficacy and Safety in Adults with Systemic Lupus Erythematosus and Active Lupus Nephritis
BulgariaStudy of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications
BulgariaEvaluation of Trazodone Hydrochloride for Improving Emotional Blunting in Patients with Major Depressive Disorder
BulgariaAsthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate
BulgariaKAI-9531 in Adults With Obesity or Overweight and Diabetes
BulgariaA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
BulgariaStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Ongoing research focuses on influenza virus prevention and hepatitis delta infection treatment. Clinical trials are evaluating new vaccine formulations and therapeutic approaches for viral infections.
Studies include testing of adjuvanted vaccines and novel antiviral medications for chronic conditions.
Research initiatives targeting hypertriglyceridemia and heart failure prevention. Studies are exploring innovative treatments for metabolic conditions and cardiovascular risk reduction.
Trials evaluate new compounds for managing metabolic disorders and preventing cardiovascular events.
Comprehensive studies on psoriatic arthritis, Sjögren's disease, and systemic sclerosis. Research focuses on innovative biological therapies and treatment approaches.
Clinical trials are investigating novel therapeutic agents for managing chronic autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
